There is a chasm in the path from basic biomedical research discoveries to their clinical application owing to inadequate funding for support of proof-of-conceptor validation studies for early-stage development of new technologies…

Fonte: NATURE REVIEWS | DRUG DISCOVERY VOLUME 16 | OCTOBER 2017 | 1

Para acessar a publicação na íntegra clique  aqui